Boston Scientific Corp
A maker of medical devices for less-invasive procedures, Boston Scientific builds tools like the WATCHMAN heart implant, the FARAPULSE system for treating irregular heartbeats, and devices for endoscopy, urology, and pain management, sold in more than a hundred countries. Founded in 1979 by John Abele and Pete Nicholas, the company began as a holding company for a steerable-catheter maker and took its name from its Massachusetts roots plus the founders' commitment to scientific rigor. The two founders reportedly met while watching their children play soccer.
Granted 415.5K · Sold 160.9K
Granted 234.4K · Sold 150.0K
Granted 80.8K · Sold 17.3K
Granted 35.9K
Granted 3.8K
Granted 5.0K
Granted 3.8K · Sold 25.8K
Granted 3.8K · Bought 3.6K
Granted 3.7K
Granted 3.8K · Bought 4.5K
Granted 5.1K · Bought 2.0K
Granted 3.8K
Granted 5.5K
Granted 4.0K
Granted 3.8K
Bought 1.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Mahoney Michael FChairman, President & CEO, Director · 18 transactions | -20.6% | 1.40M | 415.5K | — | 160.9K |
| Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology · 22 transactions | -3% | 404.9K | 234.4K | — | 150.0K |
| Butcher Arthur CEVP& Grp Pres, MedSurg & APAC · 18 transactions | +46.7% | 78.1K | 80.8K | — | 17.3K |
| Brown Vance REVP, GC and Corp. Secretary · 10 transactions | +64.8% | 55.1K | 35.9K | — | — |
| Wichmann David SDirector · 1 transaction | +9.1% | 45.4K | 3.8K | — | — |
| Monson JonathanEVP and CFO · 8 transactions | +8.9% | 38.4K | 5.0K | — | — |
| Zane Ellen MDirector · 5 transactions | -24.6% | 27.9K | 3.8K | — | 25.8K |
| Ludwig Edward JDirector · 2 transactions | +41% | 25.4K | 3.8K | 3.6K | — |
| O'Sullivan MiriamSVP, Chief HR Officer · 9 transactions | — | 19.3K | 3.7K | — | — |
| Habiger David CDirector · 3 transactions | +146.6% | 13.9K | 3.8K | 4.5K | — |
| Morano Susan EDirector · 4 transactions | +128.4% | 13.8K | 5.1K | 2.0K | — |
| Mega Jessica LDirector · 1 transaction | +46.1% | 12.0K | 3.8K | — | — |
| O'Connor Padraig AndrewEVP, Global Operations · 10 transactions | — | 7.9K | 5.5K | — | — |
| Woodworth EmilySVP, Global Controller and CAO · 10 transactions | +561.8% | 2.9K | 4.0K | — | — |
| Weber Christophe PierreDirector · 4 transactions | — | 2.6K | 3.8K | — | — |
| Pegus CherylDirector · 1 transaction | — | 1.8K | — | 1.8K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -342.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.